NCT03119194View on ClinicalTrials.gov

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Parkinson Disease
Interventions
DRUG

[14C]-BIA 9-1067

1 × 100 mg capsule, Oral

Trial Locations (1)

NG11 6JS

Quotient Clinical, Ruddington

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT03119194 - Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-BIA 9-1067 | Biotech Hunter | Biotech Hunter